Julia Belladonna
Direktor der Forschung - Eigenkapital bei Leerink Partners LLC
Aktive Positionen von Julia Belladonna
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Analyst-Equity | 01.10.2021 | - |
| Direktor der Forschung - Eigenkapital | 01.10.2021 | - |
Karriereverlauf von Julia Belladonna
Ausbildung von Julia Belladonna
| Williams College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
| Analyst-Equity | 1 |
Sektoral
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
- Börse
- Insiders
- Julia Belladonna
- Erfahrung
